These independent CME activities are supported by educational grants from Bristol-Myers Squibb.



    Hematology Mastery in
  Multiple Myeloma
  1. Course List
CME/CE Information

Target Audience

This series of activities is designed for hematologists, oncologists, radiologists, primary care physicians, nurse practitioners, and other clinicians involved in the screening and treatment of patients with multiple myeloma.

Activity Goal

The goal of this program is to provide information and case studies at the point of care on current and emerging management strategies based on the most up-to-date evidence-based medicine and clinical trial results in multiple myeloma.

Learning Objective (s)

  • Evaluate criteria that have been developed to assess treatment response in multiple myeloma and delineate how these criteria can be used to risk-stratify patients in clinical practice.
  • Formulate personalized treatment regimens that improve patient outcomes based on an understanding of the mechanism of action, efficacy, and safety profiles of current and emerging treatment options.

Instructions


To obtain credit:

  1. Read or listen to each activity carefully.
  2. Complete/submit each posttest and evaluation.
  3. Instantly access and print out your certificate.

There is no fee for this activity.

CONTRACT FOR MUTUAL RESPONSIBILITY IN

Projects In Knowledge has developed the contract to demonstrate our commitment to providing the highest quality professional education to clinicians, and to help clinicians set educational goals to challenge and enhance their learning experience.

For more information on the contract, click here.
Disclosure Information

Noopur Raje, MD has received consulting fees from Amgen Inc., Celgene Corporation, Millennium Pharmaceuticals, Inc., and Onyx Pharmaceuticals, Inc.; and has conducted contracted research for Acetylon Pharmaceuticals, Inc. and Eli Lilly and Company.

Jonathan L. Kaufman, MD

Suzanne Lentzsch, MD, PhD

Sagar Lonial, MD has received consulting fees from Bristol-Myers Squibb, Celgene Corporation, Janssen Pharmaceuticals, Inc., Millennium Pharmaceuticals, Inc., Novartis Pharmaceuticals Corporation, Onyx Pharmaceuticals, Inc., and Sanofi-Aventis.

Ajay K. Nooka, MD, MPH has received consulting fees from Amgen Inc., Novartis Pharmaceuticals Corporation, and Spectrum Pharmaceuticals.

Peer Reviewer has disclosed no relevant relationships.

Projects In Knowledge's staff members have disclosed no relevant relationships.

These activities may contain discussions of unlabeled/unapproved uses of drugs or devices. Specific product disclosure will be forthcoming in each activity.

The opinions expressed in these activities are those of the faculty and do not necessarily reflect those of Projects In Knowledge.

This activity is provided solely as an educational service. Specific patient care decisions are the responsibility of the clinician caring for the patient.

These independent CME activities are supported by educational grants from Bristol-Myers Squibb.

Projects In Knowledge is a registered trademark of Projects In Knowledge, Inc.

2304